(Q27824811)

English

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

scientific article

Statements

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit